Results 31 to 40 of about 116,083 (186)

NTRK Fusions in 1113 Solid Tumors in a Single Institution

open access: yesDiagnostics, 2022
Most NTRK fusions occur at very low frequencies in various common cancers. Recent recommendations on NTRK testing recommend immunohistochemistry (IHC) as the initial test for tumor types with a low frequency of NTRK fusions.
Heejin Bang   +7 more
doaj   +1 more source

Pharmacological Topics of Bone Metabolism: A Novel Bisphosphonate for the Treatment of Periodontitis

open access: yesJournal of Pharmacological Sciences, 2008
It has been reported that the pharmacological characteristics of bisphosphonates vary depending on the side chain attached to the carbon atom of the P-C-P bond.
Hisashi Shinoda   +4 more
doaj   +1 more source

On Trk for Retrograde Signaling [PDF]

open access: yesNeuron, 2001
Target-derived neurotrophins like nerve growth factor (NGF) mediate biological effects by binding to and activating Trk neurotrophin receptors at nerve terminals. The activated Trk receptors then stimulate local effects at nerve terminals, and retrograde effects at neuronal cell bodies that often reside at considerable distances from the terminals ...
Miller, Freda D, Kaplan, David R
openaire   +2 more sources

Keeping ‘Trk’ of Antidepressant Actions [PDF]

open access: yesNeuron, 2008
Despite growing evidence that increased brain-derived neurotrophic factor (BDNF) and hippocampal adult neurogenesis are necessary for the behavioral actions of antidepressants in rodents, the cellular mechanisms involved in these effects are still unknown. Li et al.
Banasr, Mounira, Duman, Ronald S.
openaire   +2 more sources

Neurotrophin and Trk expression by cells of the human lamina cribrosa following oxygen-glucose deprivation

open access: yesBMC Neuroscience, 2004
Background Ischemia within the optic nerve head (ONH) may contribute to retinal ganglion cell (RGC) loss in primary open angle glaucoma (POAG). Ischemia has been reported to increase neurotrophin and high affinity Trk receptor expression by CNS neurons ...
Clark Abbot F   +2 more
doaj   +1 more source

Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China

open access: yesThoracic Cancer, 2022
Gene fusions can drive tumor development for multiple types of cancer. Currently, many drugs targeting gene fusions are being approved for clinical application.
Chunwei Xu   +110 more
doaj   +1 more source

Unraveling the molecular mechanism of novel leukemia mutations on NTRK2 (A203T & R458G) and NTRK3 (E176D & L449F) genes using molecular dynamics simulations approach [version 2; peer review: 2 approved, 1 approved with reservations]

open access: yesF1000Research
Background: NTRK1, NTRK2, and NTRK3 are members of the neurotrophic receptor tyrosine kinases (NTRK) family, which encode TrkA, TrkB, and TrkC receptors, respectively.
Fazil Ahmad   +3 more
doaj   +1 more source

Involvement of TRK receptors in the nootropic effect of cycloprolylglycine

open access: yesФармакокинетика и Фармакодинамика
Background. The neuropeptide cycloprolylglycine (CPG) is an endogenous dipeptide analogue of the nootropic piracetam. It has been experimentally shown that CPG (designed and synthesized at the Federal State Budgetary Scientific Institution «Federal ...
O. N. Vorontsova   +5 more
doaj   +1 more source

Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib

open access: yesBMC Cancer, 2022
Background Tropomyosin receptor kinase (TRK) fusion proteins resulting from neurotrophic tyrosine receptor kinase (NTRK) gene fusions are rare primary oncogenic drivers in a wide array of tumors.
James C. H. Yang   +15 more
doaj   +1 more source

In Silico Design and Verification of LAMP-BDNF Chimeric Protein for Presentation of BDNF on the Surface of Exosomes for Drug Delivery Through Blood-Brain Barrier

open access: yesJournal of Mazandaran University of Medical Sciences, 2022
Background and purpose: The mature form of brain-derived neurotrophic factor (BDNF) binds to BDNF/NT-3 growth factors receptor (Trk-B). This binding leads to activation of Ras–MAPK pathway which is integrated with cell growth and proliferation.
Saeed Khalili   +8 more
doaj  

Home - About - Disclaimer - Privacy